Clinical Trials Browser

Phase 1 × NIH × Introns × Clear all

NCT00217373 2015-04-20

Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)

Phase 1 Completed

Adult Solid Neoplasm

NCT00217542 2013-05-03

Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery

Phase 1 Completed

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma